Uterine serous and clear cell carcinomas: Hormonal profile and expression of steroid hormone receptors in mitochondria.
Abstract
e17624 Background: Uterine serous carcinoma (USC) and clear cell carcinoma (CCC) are rare but aggressive histological subtypes of endometrial cancer associated with a poor prognosis. Beyond their classical role in energy metabolism, mitochondria are involved in cell signaling. Steroid hormone receptors are localized within mitochondria, allowing estrogens, progesterone, and androgens to directly influence mitochondrial function, thereby regulating apoptosis and energy metabolism. The aim of this study was a comparative assessment of steroid hormone levels and their receptor expression in mitochondria isolated from USC and CCC tissues versus mitochondria from intact endometrium. Methods: Mitochondria were isolated from tumor tissues of 41 patients with rare forms of endometrial cancer: USC (n=21) and CCC (n=20). All patients presented with stage III–IV, high-grade (G3) disease; the mean age was 59.6±6.7 years. Mitochondria from histologically normal (intact) endometrium (n=20) obtained from women undergoing surgery for uterine fibroids (mean age 57.8±8.2 years) served as controls. Concentrations of estrone (E1), estradiol (E2), estriol (E3), testosterone (T), progesterone (P4), and receptors (ERα, ERβ, AR, PR) were determined in the purified mitochondrial fraction using enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using parametric and nonparametric tests with adjustments for multiple comparisons. Results: In USC and CCC mitochondria, a statistically significant (p < 0.05) increase was observed compared to the control group for: E2 (1.3- to 2-fold), E3 (1.8- to 2.2-fold), P4 and T (1.5-fold on average), ERβ (more than 2-fold), and PR (3.4- to 5.2-fold). However, ERα and AR levels were significantly increased only in USC (1.8-fold, p < 0.05 and 2.2-fold, p < 0.05, respectively), whereas no significant differences were found in CCC mitochondria. Conclusions: The findings demonstrate significant alterations in the mitochondrial hormonal and receptor profiles in serous and clear cell endometrial carcinomas. Overexpression of ERβ and PR, alongside the accumulation of steroid hormones, indicates the activation of mitochondrial hormonal signaling pathways. The observed differences suggest distinct mechanisms of hormonal regulation: estrogen- and androgen-dependent signaling predominates in USC, while progesterone-dependent signaling predominates in CCC. These features may determine differences in the biological behavior of these tumors and their response to therapy.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (20)
Anna Petrovna Menshenina
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Elena M. Frantsiyants
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Valeria Bandovkina
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Tatiana I. Moiseenko
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Mark A. Rogozin
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Ekaterina I. Surikova
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Irina Valerevna Neskubina
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Alla A. Adamyan
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Oksana E. Kravtsova
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Olga Selezneva
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Elena A. Ozerkova
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Elena V. Shalashnaya
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Sofya A. Kornienko
Rostov State Medical University, Rostov-on-Don, Russian Federation
Ekaterina V. Verenikina
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Zlata V. Verenikina
Rostov State Medical University, Rostov-on-Don, Russian Federation
Larisa N. Vashchenko
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Iuliana S. Shatova
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Anna Yurevna Ardzha
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Arthur Andryasovich Antonyan
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Oleg Ivanovich Kit
National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation